LCM
ANVS icon

Lynwood Capital Management’s Annovis Bio ANVS Stock Holding History

Lynwood Capital Management’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,131
Closed -$145K – 76
2023
Q2 		$145K Buy
+10,131
New +$143K 0.18% 71
2022
Q3 		– Sell
-12,500
Closed -$142K – 147
2022
Q2 		$142K Buy
+12,500
New +$137K 0.16% 86

Other funds holding ANVS

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lynwood Capital Management's ANVS Position: Q3 2023 in Review

Lynwood Capital Management sold out of Annovis Bio (ANVS) in Q3 2023, closing a stake of 10,131 shares — an estimated $145K sold.

Lynwood Capital Management first reported a position in ANVS in Q2 2022 and held it in 2 quarters. The position peaked at $145K in Q2 2023. 30 funds tracked by Wall St. Rank hold ANVS as of Q3 2023.

  • Lynwood Capital Management reported no remaining Annovis Bio position as of Q3 2023 after selling out during the quarter.
  • Lynwood Capital Management sold 10,131 Annovis Bio shares in Q3 2023, an estimated $145K.
  • Lynwood Capital Management first reported a position in Annovis Bio in Q2 2022 and held it in 2 quarters.
  • Lynwood Capital Management's Annovis Bio position peaked at $145K in Q2 2023.
  • 30 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2023.

Based on Lynwood Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.